218 related articles for article (PubMed ID: 16879756)
21. Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy.
Pugnale P; Herrmann E; Neumann AU; Pawlotsky JM; Schalm SW; Ferrari C; Homburger Y; Zeuzem S; Negro F;
J Hepatol; 2008 Jun; 48(6):932-8. PubMed ID: 18433918
[TBL] [Abstract][Full Text] [Related]
22. Rapid HCV-RNA decline with once daily TMC435: a phase I study in healthy volunteers and hepatitis C patients.
Reesink HW; Fanning GC; Farha KA; Weegink C; Van Vliet A; Van 't Klooster G; Lenz O; Aharchi F; Mariën K; Van Remoortere P; de Kock H; Broeckaert F; Meyvisch P; Van Beirendonck E; Simmen K; Verloes R
Gastroenterology; 2010 Mar; 138(3):913-21. PubMed ID: 19852962
[TBL] [Abstract][Full Text] [Related]
23. Detection of hepatitis C virus in the semen of infected men.
Leruez-Ville M; Kunstmann JM; De Almeida M; Rouzioux C; Chaix ML
Lancet; 2000 Jul; 356(9223):42-3. PubMed ID: 10892766
[TBL] [Abstract][Full Text] [Related]
24. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs.
Rockstroh JK; Theisen A; Kaiser R; Sauerbruch T; Spengler U
AIDS; 1998 May; 12(7):829-30. PubMed ID: 9619824
[No Abstract] [Full Text] [Related]
25. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
Charlton M; Gane E; Manns MP; Brown RS; Curry MP; Kwo PY; Fontana RJ; Gilroy R; Teperman L; Muir AJ; McHutchison JG; Symonds WT; Brainard D; Kirby B; Dvory-Sobol H; Denning J; Arterburn S; Samuel D; Forns X; Terrault NA
Gastroenterology; 2015 Jan; 148(1):108-17. PubMed ID: 25304641
[TBL] [Abstract][Full Text] [Related]
26. Estimation of inhibitory quotient using a comparative equilibrium dialysis assay for prediction of viral response to hepatitis C virus inhibitors.
Mo H; Yang C; Wang K; Wang Y; Huang M; Murray B; Qi X; Sun SC; Deshpande M; Rhodes G; Miller MD
J Viral Hepat; 2011 May; 18(5):338-48. PubMed ID: 20456634
[TBL] [Abstract][Full Text] [Related]
27. Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women.
Bernabucci V; Ciancio A; Petta S; Karampatou A; Turco L; Strona S; Critelli R; Todesca P; Cerami C; Sagnelli C; Rizzetto M; Cammà C; Villa E
World J Gastroenterol; 2014 Nov; 20(44):16726-33. PubMed ID: 25469044
[TBL] [Abstract][Full Text] [Related]
28. Correlates and prognostic value of the first-phase hepatitis C virus RNA kinetics during treatment.
Durante-Mangoni E; Zampino R; Portella G; Adinolfi LE; Utili R; Ruggiero G
Clin Infect Dis; 2009 Aug; 49(4):498-506. PubMed ID: 19591593
[TBL] [Abstract][Full Text] [Related]
29. Simeprevir with peginterferon and ribavirin leads to high rates of SVR in patients with HCV genotype 1 who relapsed after previous therapy: a phase 3 trial.
Forns X; Lawitz E; Zeuzem S; Gane E; Bronowicki JP; Andreone P; Horban A; Brown A; Peeters M; Lenz O; Ouwerkerk-Mahadevan S; Scott J; De La Rosa G; Kalmeijer R; Sinha R; Beumont-Mauviel M
Gastroenterology; 2014 Jun; 146(7):1669-79.e3. PubMed ID: 24602923
[TBL] [Abstract][Full Text] [Related]
30. Lasso regularization for left-censored Gaussian outcome and high-dimensional predictors.
Soret P; Avalos M; Wittkop L; Commenges D; Thiébaut R
BMC Med Res Methodol; 2018 Dec; 18(1):159. PubMed ID: 30514234
[TBL] [Abstract][Full Text] [Related]
31. Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV co-infected patients.
Bader T
J Viral Hepat; 2010 Mar; 17(3):227. PubMed ID: 19758277
[No Abstract] [Full Text] [Related]
32. Analysis of hepatitis C viral kinetics during administration of two nucleotide analogues: sofosbuvir (GS-7977) and GS-0938.
Guedj J; Pang PS; Denning J; Rodriguez-Torres M; Lawitz E; Symonds W; Perelson AS
Antivir Ther; 2014; 19(2):211-20. PubMed ID: 24464551
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of left-censored quantitative outcome: example of procalcitonin level].
Asselineau J; Thiébaut R; Perez P; Pinganaud G; Chêne G
Rev Epidemiol Sante Publique; 2007 Jun; 55(3):213-20. PubMed ID: 17467942
[TBL] [Abstract][Full Text] [Related]
34. Frequency of very low HCV viremia detected by a highly sensitive HCV-RNA assay.
Fytili P; Tiemann C; Wang C; Schulz S; Schaffer S; Manns MP; Wedemeyer H
J Clin Virol; 2007 Aug; 39(4):308-11. PubMed ID: 17625963
[TBL] [Abstract][Full Text] [Related]
35. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
Gallegos-Orozco JF; Fuentes AP; Olivera-Martinez MA; Gutiérrez-Reyes G; Cortina D; Oregel JA; Pérez-Pruna C; Sixtos MS; Cruz-Castellanos S; Soto-Ramírez LE; Rodríguez-Díaz R; Fuentes-Romero L; Gutiérrez-Ruiz MC; Kershenobich D
Rev Invest Clin; 2003; 55(2):138-42. PubMed ID: 12827916
[TBL] [Abstract][Full Text] [Related]
36. Low hepatitis C viral load predicts better long-term outcomes in patients undergoing resection of hepatocellular carcinoma irrespective of serologic eradication of hepatitis C virus.
Shindoh J; Hasegawa K; Matsuyama Y; Inoue Y; Ishizawa T; Aoki T; Sakamoto Y; Sugawara Y; Makuuchi M; Kokudo N
J Clin Oncol; 2013 Feb; 31(6):766-73. PubMed ID: 23129744
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol].
Pivert A; Payan C; Lunel F;
Pathol Biol (Paris); 2004 Nov; 52(9):522-8. PubMed ID: 15531116
[TBL] [Abstract][Full Text] [Related]
38. Methods for Handling Left-Censored Data in Quantitative Microbial Risk Assessment.
Canales RA; Wilson AM; Pearce-Walker JI; Verhougstraete MP; Reynolds KA
Appl Environ Microbiol; 2018 Oct; 84(20):. PubMed ID: 30120116
[TBL] [Abstract][Full Text] [Related]
39. Clinical trial simulation to evaluate power to compare the antiviral effectiveness of two hepatitis C protease inhibitors using nonlinear mixed effect models: a viral kinetic approach.
Laouénan C; Guedj J; Mentré F
BMC Med Res Methodol; 2013 Apr; 13():60. PubMed ID: 23617810
[TBL] [Abstract][Full Text] [Related]
40. Triphasic decline of hepatitis C virus RNA during antiviral therapy.
Dahari H; Ribeiro RM; Perelson AS
Hepatology; 2007 Jul; 46(1):16-21. PubMed ID: 17596864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
